 - Diagnosis of solid tumour and completion of adjuvant chemotherapy andor radiotherapy with curative intent within the preceding 2-6 months. Patients who have received neoadjuvant chemotherapy or chemoradiotherapy followed by surgery will also be eligible. In addition, patients continuing onto adjuvant hormone therapy and anti-Her2 directed therapy are eligible. 